Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 4Sanofi
02 2Dr. Reddy's Laboratories
03 2ANI Pharmaceuticals Inc
04 6Accord healthcare
05 2Actavis Inc
06 2Alembic Pharmaceuticals Limited
07 2Alkem Laboratories
08 2Amneal Pharmaceuticals
09 2Ascent Innovative Medicines
10 2Aurobindo Pharma Limited
11 2CHEMO
12 2Chartwell Pharmaceuticals llc
13 4Farm Agon
14 3GL Pharma
15 2Hetero Drugs
16 2Intas Pharmaceuticals
17 2Lupin Ltd
18 4Mepha Pharma
19 4ORIFARM GROUP AS
20 2Orchid Pharma
21 22Pfizer Inc
22 1Precise Group
23 4Sandoz B2B
24 2Sun Pharmaceutical Industries Limited
25 2Unichem Laboratories Limited
26 4Zentiva
27 2Zydus Pharmaceuticals
28 3Blank
01 18Depot tablet
02 10Depottablett
03 2ER TABLET
04 4ER Tablet
05 3Extended-Release Tablet
06 2PROLONGED-RELEASE TABLET
07 3Prolonged Release Tablet
08 5Ret Tabl
09 7Ret Tablet
10 2SR Tablet
11 4TABLET (EXTENDED-RELEASE)
12 30TABLET, EXTENDED RELEASE;ORAL
13 3Tablet
01 8DISCN
02 3Dossier Availability- Q2 2018
03 3Generic
04 2Generic EU CTD
05 4Prescription
06 16RX
07 57Blank
01 328 Toviaz 8Mg Extended Release Tablets
02 28FESOTERODINE FUMARATE
03 3Fesoterodin Zentiva
04 4Fesoterodin-Mepha
05 4Fesoterodine Accord
06 5Fesoterodine Zentiva
07 2SANDOZ FESOTERODINE FUMARATE
08 6TOVIAZ
09 24Toviaz
10 14Blank
01 3Austria
02 4Canada
03 9India
04 28Norway
05 5Spain
06 2Sweden
07 12Switzerland
08 30USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Switzerland
Brand Name : Fesoterodin Zentiva
Dosage Form : Ret Tablet
Dosage Strength : 4mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : FESOTERODINE FUMARATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 4MG
Packaging :
Approval Date : 2019-08-13
Application Number : 204975
Regulatory Info : RX
Registration Country : USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Switzerland
Brand Name : Fesoterodin Zentiva
Dosage Form : Ret Tablet
Dosage Strength : 8mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Switzerland
Brand Name : Fesoterodin Zentiva
Dosage Form : Ret Tablet
Dosage Strength : 8mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Switzerland
Brand Name : Fesoterodine Zentiva
Dosage Form : Ret Tabl
Dosage Strength : 4mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : FESOTERODINE FUMARATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 8MG
Packaging :
Approval Date : 2019-08-13
Application Number : 204975
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : FESOTERODINE FUMARATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 4MG
Packaging :
Approval Date : 2023-01-04
Application Number : 204868
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : FESOTERODINE FUMARATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 8MG
Packaging :
Approval Date : 2023-01-04
Application Number : 204868
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FESOTERODINE FUMARATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 4MG
Packaging :
Approval Date : 2023-01-04
Application Number : 204973
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FESOTERODINE FUMARATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 8MG
Packaging :
Approval Date : 2023-01-04
Application Number : 204973
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FESOTERODINE FUMARATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 4MG
Packaging :
Approval Date : 2015-12-10
Application Number : 204827
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FESOTERODINE FUMARATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 8MG
Packaging :
Approval Date : 2015-12-10
Application Number : 204827
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FESOTERODINE FUMARATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 4MG
Packaging :
Approval Date : 2023-01-04
Application Number : 205002
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FESOTERODINE FUMARATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 8MG
Packaging :
Approval Date : 2023-01-04
Application Number : 205002
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : FESOTERODINE FUMARATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 4MG
Packaging :
Approval Date : 2023-01-04
Application Number : 204504
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : FESOTERODINE FUMARATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 8MG
Packaging :
Approval Date : 2023-01-04
Application Number : 204504
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FESOTERODINE FUMARATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 4MG
Packaging :
Approval Date : 2017-02-17
Application Number : 205007
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FESOTERODINE FUMARATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 8MG
Packaging :
Approval Date : 2017-02-17
Application Number : 205007
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : FESOTERODINE FUMARATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 4MG
Packaging :
Approval Date : 2023-01-05
Application Number : 204983
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : FESOTERODINE FUMARATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 8MG
Packaging :
Approval Date : 2023-01-05
Application Number : 204983
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FESOTERODINE FUMARATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 4MG
Packaging :
Approval Date : 2024-01-09
Application Number : 204792
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FESOTERODINE FUMARATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 8MG
Packaging :
Approval Date : 2024-01-09
Application Number : 204792
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : FESOTERODINE FUMARATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 4MG
Packaging :
Approval Date :
Application Number : 204893
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : FESOTERODINE FUMARATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 8MG
Packaging :
Approval Date :
Application Number : 204893
Regulatory Info :
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : TOVIAZ
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 4MG
Packaging :
Approval Date : 2008-10-31
Application Number : 22030
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : TOVIAZ
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 8MG
Packaging :
Approval Date : 2008-10-31
Application Number : 22030
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : FESOTERODINE FUMARATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 4MG
Packaging :
Approval Date :
Application Number : 204844
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : FESOTERODINE FUMARATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 8MG
Packaging :
Approval Date :
Application Number : 204844
Regulatory Info :
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FESOTERODINE FUMARATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 4MG
Packaging :
Approval Date : 2017-10-03
Application Number : 204946
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FESOTERODINE FUMARATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 8MG
Packaging :
Approval Date : 2017-10-03
Application Number : 204946
Regulatory Info : RX
Registration Country : USA
LOOKING FOR A SUPPLIER?
